Genomic imprinting of IGF2 and H19 in human meningiomas

European Journal of Cancer

Volumn 36, Issue 5, 2000, Pages 651-655

  Muller S ^a   Zirkel, D ^a   Westphal, M ^a   Zumkeller, W ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

H19; IGF2; Imprinting; Meningioma

Indexed keywords

GROWTH FACTOR; MESSENGER RNA;

ADULT; AGED; ALLELE; ARTICLE; CARCINOGENESIS; CHOROID PLEXUS TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOME IMPRINTING; HEREDITY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; MENINGOCELE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; FEMALE; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MUSCLE PROTEINS; POLYMERASE CHAIN REACTION; RNA, UNTRANSLATED;

EID: 0342905139     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00328-7     Document Type: Article

References (41)

1. Louis D.N., Ramesh V., Gusella J.F. Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol. 5:1995;163-172.
2. Louis DN, Budka H, von Deimling A. Meningiomas. In Kleihues P, Cavenee WK, eds. Tumours of the Nervous System. Lyon, International Agency for Cancer Research, 1997, 133-141.
3. Efstratiadis A. Parental imprinting of autosomal genes. Curr. Opin. Genet. Dev. 4:1994;265-280.
4. Joyce J.A., Schofield P.N. Genomic imprinting and cancer. J. Clin. Pathol.: Mol. Pathol. 51:1998;185-190.
5. Weksberg R., Shen D.R., Fei Y.L., Song Q.L., Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet. 5:1993;143-150.
6. Steenman M.J.C., Rainier S., Dobry C.J., Grundy P., Horon I.L., Feinberg A.P. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet. 7:1994;433-439.
7. Ogawa O., Eccles M.R., Szeto J.et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature. 362:1993;749-751.
8. Rotwein P. Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors. 5:1991;3-18.
9. De Chiara T.M., Robertson E.J., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 64:1991;849-859.
10. Albrecht S., Waha A., Koch A., Kraus J.A., Goodyer C.G., Pietsch T. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma. J. Neuropathol. Exp. Neurol. 55:1996;1270-1276.
11. Uyeno S., Aoki Y., Nata M.et al. IGF2 but not H19 shows loss of imprinting in human glioma. Cancer Res. 56:1996;5356-5359.
12. Poirier F., Chan C.T.J., Timmons P.M., Robertson E.J., Evans M.J., Rigby P.W.J. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development. 113:1991;1105-1114.
13. Zhang Y., Shields T., Crenshaw T., Hao Y., Moulton T., Tycko B. Imprinting of human H19. allele-specific CpG methylation, loss of the active allele in Wilms' tumor and potential for somatic allele switching Am. J. Hum. Genet. 53:1993;113-124.
14. Ohlsson R., Hedborg F., Holmgren L., Walsh C., Ekström T.J. Overlapping patterns of IGF2 and H19 expression during human development. biallelic IGF2 expression correlates with a lack of H19 expression Development. 120:1994;361-368.
15. Zemel S., Bartolomei M.S., Tilghman S. Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor. Nature Genet. 2:1992;61-65.
16. Brannan C.I., Dees E.C., Ingram R.S., Tilghman S. The product of the H19 gene may function as an RNA. Mol. Cell. Biol. 10:1990;28-36.
17. Li Y.M., Franklin G., Cui H.M.et al. The H19 transcript is associated with polysomes and may regulate IGF2 expression in trans. J. Biol. Chem. 273:1998;28247-28252.
18. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumour-suppressor activity of H19 RNA. Nature. 365:1993;764-767.
19. Moulton T., Crenshaw T., Hao Y.et al. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet. 7:1994;440-447.
20. Zumkeller W., Schwab M. Insulin-like growth factor system in neuroblastoma tumorigenesis and apoptosis. potential diagnostic and therapeutic perspectives Horm. Metab. Res. 31:1999;138-141.
21. Lichtor L., Kurpakus M.A., Gurney M.E. Differential expression of insulin-like growth factor II in human meningiomas. Neurosurgery. 29:1991;405-410.
22. Antoniades H.N., Galanopoulos T., Neville-Golden J., Maxwell M. Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas. in vivo studies using in situ hybridization and immunocytochemistry Int. J. Cancer. 50:1992;215-222.
23. Sandberg-Nordqvist A.C., Peyrard M., Pettersson H.et al. A high ratio of insulin-like growth factor II/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas. Cancer Res. 57:1997;2611-2614.
24. Hashimoto K., Azuma C., Koyama M.et al. Loss of imprinting in choriocarcinoma. Nature Genet. 9:1995;109-110.
25. Tadokoro K., Fujii H., Inoue T., Yamada M. Polymerase chain reaction (PCR) for detection of ApaI polymorphism at the insulin like growth factor II gene (IGF2). Nucleic Acids Res. 19:1991;6967.
26. Yballe C.M., Vu T.H., Hoffman A.R. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast carcinoma. J. Clin. Endocrinol. Metab. 81:1996;1607-1612.
27. Werner H., LeRoith D. The role of the insulin-like growth factor system in the human cancer. Adv. Cancer Res. 68:1996;183-223.
28. Rainier S., Johnson L.A., Dobry C.J., Ping A.J., Grundy P.E., Feinberg A.P. Relaxation of imprinted genes in human cancer. Nature. 362:1993;747-749.
29. Ogawa O., Becroft D.M., Morison I.M.et al. Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism. Nature Genet. 5:1993;408-412.
30. Pedone P.V., Cosma M.P., Ungaro P.et al. Parental imprinting of rat insulin-like growth factor II gene promoters is coordinately regulated. J. Biol. Chem. 269:1994;23970-23975.
31. Suzuki H., Ueda R., Takahashi T., Takahashi T. Altered imprinting in lung cancer. Nature Genet. 6:1994;332-333.
32. Davies S.M. Maintanance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Res. 53:1993;4781-4783.
33. Barletta J.M., Rainier S., Feinberg A.P. Reversal of loss of imprinting in tumor cells by 5-aza-2′-deoxycytidine. Cancer Res. 57:1997;48-50.
34. Bartolomei M.S., Zemel S., Tilghman S.M. Parental imprinting of the mouse H19 gene. Nature. 351:1991;153-155.
35. Razin A., Cedar H. DNA methylation and genomic imprinting. Cell. 77:1994;473-476.
36. Pfeifer K., Tilghman S.M. Allele-specific gene expression in mammals. the curious case of the imprinted RNAs Genes Dev. 8:1994;1867-1874.
37. Rainier S., Dobry C.J., Feinberg A.P. Loss of imprinting in hepatoblastoma. Cancer Res. 55:1995;1836-1838.
38. Zumkeller W., Biernoth R., Kocialkowski S.et al. Expression and synthesis of insulin-like growth factor (IGF)-I, -II and their receptors in human glioma cell lines. Int. J. Oncol. 9:1996;983-992.
39. Sell C., Baserga R., Rubin R. Insulin-like growth factor (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 55:1995;303-306.
40. Ohlsson R., Cui H., He L.et al. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity. Cancer Res. 59:1999;3889-3892.
41. Pham N.V., Nguyen M.T., Hu J.F., Vu T.H., Hoffman A.R. Dissociation of IGF2 and H19 imprinting in human brain. Brain Res. 10:1998;1-8.